Zhejiang Yongtai Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZHEJIANG YONGTAI
ZHEJIANG YONGTAI has four approved drugs.
Summary for Zhejiang Yongtai
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Zhejiang Yongtai
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Yongtai | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 212059-003 | Nov 4, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zhejiang Yongtai | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 212059-001 | Nov 4, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zhejiang Yongtai | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 217022-002 | Dec 27, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zhejiang Yongtai | DOXYCYCLINE HYCLATE | doxycycline hyclate | CAPSULE;ORAL | 212610-002 | Mar 31, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
